首页> 外文期刊>Journal of Molecular Biology >Viral RNAi suppressor reversibly binds siRNA to outcompete Dicer and RISC via multiple turnover.
【24h】

Viral RNAi suppressor reversibly binds siRNA to outcompete Dicer and RISC via multiple turnover.

机译:病毒RNAi抑制剂可通过多次转换将siRNA可逆地结合到Dicer和RISC之上。

获取原文
获取原文并翻译 | 示例
           

摘要

RNA interference is a conserved gene regulatory mechanism employed by most eukaryotes as a key component of their innate immune response to viruses and retrotransposons. During viral infection, the RNase-III-type endonuclease Dicer cleaves viral double-stranded RNA into small interfering RNAs (siRNAs) 21-24 nucleotides in length and helps load them into the RNA-induced silencing complex (RISC) to guide the cleavage of complementary viral RNA. As a countermeasure, many viruses have evolved viral RNA silencing suppressors (RSS) that tightly, and presumably quantitatively, bind siRNAs to thwart RNA-interference-mediated degradation. Viral RSS proteins also act across kingdoms as potential immunosuppressors in gene therapeutic applications. Here we report fluorescence quenching and electrophoretic mobility shift assays that probe siRNA binding by the dimeric RSS p19 from Carnation Italian Ringspot Virus, as well as by human Dicer and RISC assembly complexes. We find that the siRNA:p19 interaction is readily reversible, characterized by rapid binding [(1.69 +/- 0.07) x 10(8) M(-)(1) s(-1)] and marked dissociation (k(off)=0.062 +/- 0.002 s(-1)). We also observe that p19 efficiently competes with recombinant Dicer and inhibits the formation of RISC-related assembly complexes found in human cell extract. Computational modeling based on these results provides evidence for the transient formation of a ternary complex between siRNA, human Dicer, and p19. An expanded model of RNA silencing indicates that multiple turnover by reversible binding of siRNAs potentiates the efficiency of the suppressor protein. Our predictive model is expected to be applicable to the dosing of p19 as a silencing suppressor in viral gene therapy.
机译:RNA干扰是一种保守的基因调控机制,被大多数真核生物用作对其病毒和逆转座子的固有免疫反应的关键组成部分。在病毒感染期间,RNase-III型核酸内切酶Dicer可以将病毒双链RNA切割成长度为21-24个核苷酸的小干扰RNA(siRNA),并有助于将其加载到RNA诱导的沉默复合体(RISC)中,以指导切割互补病毒RNA。作为一种对策,许多病毒已经进化出病毒RNA沉默抑制剂(RSS),该抑制剂可以紧密地(可能是定量地)与siRNA结合,以阻止RNA干扰介导的降解。病毒RSS蛋白还可以跨界发挥作用,在基因治疗应用中作为潜在的免疫抑制剂。在这里,我们报告了荧光猝灭和电泳迁移率迁移分析,该探针检测来自康乃馨意大利环斑病毒的二聚RSS p19以及人Dicer和RISC组装复合物的siRNA结合。我们发现,siRNA:p19相互作用是可逆的,其特征是快速结合[(1.69 +/- 0.07)x 10(8)M(-)(1)s(-1)]和明显的解离(k(off) = 0.062 +/- 0.002 s(-1))。我们还观察到p19与重组Dicer有效竞争,并抑制人细胞提取物中发现的RISC相关装配复合物的形成。基于这些结果的计算模型为siRNA,人类Dicer和p19之间三元复合物的瞬时形成提供了证据。 RNA沉默的扩展模型表明,通过siRNA的可逆结合进行的多次转换增强了抑制蛋白的效率。我们的预测模型有望适用于p19在病毒基因治疗中作为沉默抑制剂的剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号